Michael Gelband’s Houghton Mifflin Harcourt Company HMHC Stock Holding History

Michael Gelband’s Portfolio HMHC Stock Details HMHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-160,422	Closed	-$3.37M	–	2763
2022 Q1	$3.37M	Sell	160,422 -104,840	-40%	-$1.98M	0.04%	546
2021 Q4	$4.27M	Buy	265,262 +253,700	+2,194%	+$3.86M	0.04%	492
2021 Q3	$155K	Sell	11,562 -3,923	-25%	-$49.4K	﹤0.01%	1831
2021 Q2	$171K	Buy	+15,485	New	+$146K	﹤0.01%	2032
2020 Q4	–	Sell	-43,544	Closed	-$75K	–	2534
2020 Q3	$75K	Buy	43,544 +11,165	+34%	+$24.9K	﹤0.01%	1618
2020 Q2	$59K	Buy	+32,379	New	+$52K	﹤0.01%	1676

Other funds holding HMHC

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Michael Gelband's HMHC Position: Q2 2022 in Review

Michael Gelband sold out of Houghton Mifflin Harcourt Company (HMHC) in Q2 2022, closing a stake of 160,422 shares — an estimated $3.37M sold.

Michael Gelband first reported a position in HMHC in Q2 2020 and held it in 6 quarters. The position peaked at $4.27M in Q4 2021. 1 fund tracked by Wall St. Rank holds HMHC as of Q2 2022.

Michael Gelband reported no remaining Houghton Mifflin Harcourt Company position as of Q2 2022 after selling out during the quarter.
Michael Gelband sold 160,422 Houghton Mifflin Harcourt Company shares in Q2 2022, an estimated $3.37M.
Michael Gelband first reported a position in Houghton Mifflin Harcourt Company in Q2 2020 and held it in 6 quarters.
Michael Gelband's Houghton Mifflin Harcourt Company position peaked at $4.27M in Q4 2021.
1 fund tracked by Wall St. Rank held Houghton Mifflin Harcourt Company as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.